RO6895882
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RO6895882, covering 2018-03-06 to 2018-03-06. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate Safety, Pharmacokinetics, and Efficacy of RO6895882 in Participants With Advanced and/or Metastatic Solid Tumors [Phase 1]